Stuart Pocock

London School of Hygiene & Tropical Medicine

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction”.

Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction

Circulation(2020)10.1161/circulationaha.120.051783

N/A

7.6DataRank · unranked

429 citations

Stefan D. Anker, Javed Butler, Gerasimos Filippatos, João Pedro Ferreira, Stuart Pocock +14 more

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial

Diabetes Care(2020)10.2337/dc19-2251

N/A

5.2DataRank · unranked

174 citations

Stephen C. Bain, Johannes F.E. Mann, Michael A. Nauck, Steven E. Nissen, Stuart Pocock +7 more

Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease

JAMA Cardiology(2023)10.1001/jamacardio.2023.2595

N/A

2.1DataRank · unranked

97 citations

Michael G. Nanna, Michelle D. Kelsey, Eric Yow, Daniel B. Mark, Manesh R. Patel +95 more

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies

PLoS Medicine(2007)10.1371/journal.pmed.0040296

N/A

1.5DataRank · unranked

21386 citations

Douglas G. Altman, Matthias Egger, Peter C. Gøtzsche, Jan P. Vandenbroucke, for the STROBE Initiative +2 more

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

The Lancet(2007)10.1016/s0140-6736(07)61602-x

N/A

1.5DataRank · unranked

17916 citations

Douglas G. Altman, Matthias Egger, Peter C. Gøtzsche, Jan P. Vandenbroucke, Stuart Pocock +1 more

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies

Annals of Internal Medicine(2007)10.7326/0003-4819-147-8-200710160-00010

N/A

1.5DataRank · unranked

16919 citations

Douglas G. Altman, Matthias Egger, Peter C. Gøtzsche, Jan P. Vandenbroucke, for the STROBE Initiative +2 more

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

Journal of Clinical Epidemiology(2008)10.1016/j.jclinepi.2007.11.008

N/A

1.4DataRank · unranked

15702 citations

Douglas G. Altman, Matthias Egger, Peter C. Gøtzsche, Jan P. Vandenbroucke, Stuart Pocock +1 more

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies

International Journal of Surgery(2014)10.1016/j.ijsu.2014.07.013

N/A

1.4DataRank · unranked

9776 citations

Douglas G. Altman, Matthias Egger, Peter C. Gøtzsche, Jan P. Vandenbroucke, Stuart Pocock +1 more

Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies

BMJ(2007)10.1136/bmj.39335.541782.ad

N/A

1.4DataRank · unranked

9722 citations

Douglas G. Altman, Matthias Egger, Peter C. Gøtzsche, Jan P. Vandenbroucke, Stuart Pocock +1 more

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration

PLoS Medicine(2007)10.1371/journal.pmed.0040297

N/A

1.4DataRank · unranked

8318 citations

Erik von Elm, Douglas G. Altman, Peter C. Gøtzsche, Cynthia D. Mulrow, Charles Poole +5 more

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

New England Journal of Medicine(2016)10.1056/nejmoa1603827

N/A

1.3DataRank · unranked

7197 citations

Gilbert H. Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F.E. Mann, Michael A. Nauck +13 more

Recurrent Events in Cardiovascular Trials

Journal of the American College of Cardiology(2023)10.1016/j.jacc.2023.07.024

N/A

0.574DataRank · unranked

45 citations

Gregg W. Stone, Deepak L. Bhatt, Milton Packer, Stefan D. Anker, Cordula Zeller +3 more

Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction

Open Heart(2021)10.1136/openhrt-2021-001726

N/A

0.511DataRank · unranked

7 citations

Ruth Owen, Stuart Pocock, David Brieger, Satoshi Yasuda, José Carlos Nicolau +8 more

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

UNC Libraries(2020)10.17615/5vsp-zn15

N/A

0.416DataRank · unranked

15 citations

Peter Lommer Kristensen, Lasse Steen Ravn, Richard M. Bergenstal, Stuart Pocock, Neil R. Poulter +10 more

One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial

EuroIntervention(2024)10.4244/eij-d-23-00699

N/A

0.373DataRank · unranked

11 citations

Mario Gaudino, Björn Redfors, Dominick J. Angiolillo, Ori Ben‐Yehuda, Deepak L. Bhatt +11 more

Blood pressure reduction and anti‐hypertensive treatment choice: A post‐hoc analysis of the SPRINT trial

Clinical Cardiology(2021)10.1002/clc.23591

N/A

0.312DataRank · unranked

7 citations

John Gregson, Michael Böhm, Patrick Rossignol, Faı̈ez Zannad, Stuart Pocock +1 more

Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial

UNC Libraries(2021)10.17615/4ena-v672

N/A

0DataRank · unranked

0 citations

Kirstine Brown Frandsen, Johannes F.E. Mann, John B. Buse, Steven E. Nissen, William M. Steinberg +9 more

The Win Ratio Method in Heart Failure Trials: Lessons Learnt from EMPULSE

European Journal of Heart Failure(2023)10.1002/ejhf.2853

N/A

0DataRank · unranked

44 citations

João Pedro Ferreira, Timothy Collier, Christiane E. Angermann, Jan Biegus, Sean P. Collins +11 more

Optimising the analysis of vascular prevention trials: Re-Assessment of the TARDIS trial, the first prevention trial to adopt an ordinal primary outcome measure

Contemporary Clinical Trials Communications(2023)10.1016/j.conctc.2023.101186

N/A

0DataRank · unranked

1 citations

Alan Montgomery, Stuart Pocock, Marilyn James, Annemarei Ranta, Philip M. Bath +1 more

Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial

European Heart Journal(2024)10.1093/eurheartj/ehae614

N/A

0DataRank · unranked

26 citations

Danielle Duffy, M. Cecilia Bahit, Gerald Chi, Harvey D. White, Serge Korjian +71 more

Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2024.03.396

N/A

0DataRank · unranked

30 citations

Serge Korjian, M. Cecilia Bahit, Gerald Chi, Danielle Duffy, John H. Alexander +34 more

Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study

EuroIntervention(2022)10.4244/eij-d-22-00319

N/A

0DataRank · unranked

6 citations

Frans Beerkens, George Dangas, Davide Cao, Usman Baber, Samantha Sartori +27 more

Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI

JACC: Cardiovascular Interventions(2021)10.1016/j.jcin.2020.11.046

N/A

0DataRank · unranked

38 citations

Roxana Mehran, Anna Franzone, Bruno R. da Costa, Usman Baber, Raffaele Piccolo +58 more